Home
Conditions
Myeloid Leukemia

Clinical trial condition

Myeloid Leukemia

Explore clinical trials studying Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

26 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Myeloid Leukemia trial results

Recruiting

Halt Aging in Survivors of Blood Cancers

NCT07292272

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +29 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Recruiting

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

NCT06429449

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +7 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Recruiting

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

NCT05194397

Conditions: Anemia, Anemia, Aplastic, Aplastic Anemia, +27 more
Locations: City of Hope Medical Center Duarte, California, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

NCT04260022

Conditions: B Cell Precursor Type Acute Leukemia, Blast Crisis, Bone Marrow Diseases, +35 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

Augusta Cancer Center Augusta, Georgia, United States

View Trial Details

Recruiting

Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT

NCT06130579

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Deparment of Hematology, Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML

NCT07604233

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

NCT07157514

Conditions: Acute Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, +15 more
Locations: Not specified

View Trial Details

Completed

Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland

NCT05363488

Conditions: Chromosome Aberrations, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Eatson West of Scotland Cancer Center Glasgow, United Kingdom

View Trial Details

Completed

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

NCT01760655

Conditions: Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM, +61 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

NCT04628338

Conditions: Allogeneic Stem Cell Transplantation, Bone Marrow Diseases, Graft vs Host Disease, +10 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Myeloid Leukemia

Myeloid Leukemia trial results

Related conditions